Early-Onset Alzheimer’s: Holding Out Hope

If you think Alzheimer’s disease affects only the very elderly, think again. Early-onset Alzheimer’s can strike in midlife, with devastating consequences. But hope is on the horizon.

Spotlight on Safety

This issue of BSTQ explores blood and blood products: the risks, the benefits and everything in between, as well as skin cancer, healthcare reform and more.

A People-First Approach to Leadership: Chris Ground

With a relational style and personal integrity, Chris Ground has helped FFF Enterprises cultivate a flawless safety track record.

Precious Proteins

In an industry affected by a multitude of interconnected, difficult-tocontrol variables, two things consistently stand out among manufacturers and distributors of plasma derivatives: a dedication to better patient outcomes and a passion for continuous improvement.

A New Kind of Normal

For patients like Curtis Pease who depend on immune globulin infusions, finding the right infusion setting can help streamline treatment and improve quality of life.

A Heritage of Visionary Leadership: Victor Grifols

A people-first a philosophy is interwoven throughout the Grifols company culture, impacting everything from the way products are manufactured, to the daily interactions between management and employees.

Healthcare Innovation: Changing the World— One Idea at a Time

In healthcare and pharmaceuticals, major innovations are leading to miraculous, life-saving and life-preserving advancements.

Turning Challenges into Opportunities: Mike Alkire

Mike Alkire, president of Premier Purchasing Partners Inc., on healthcare reform and nationally recognized initiatives leading the way to help solve this pressing problem.

An Ounce of Prevention

While not all diseases are vaccine-preventable, new vaccines have the potential to radically change medical treatment by treating pre-existing conditions such as HIV, cancer, multiple sclerosis, shingles and Alzheimer’s.

Leading by Example: Dr. Vas Narasimhan

Former public health physician, Dr. Vas Narasimhan has a personal passion for eradicating vaccine-preventable diseases and makes it a point to lead by example in his role as head of vaccines, Novartis North America.